Application Nr Approved Date Route Status External Links
ANDA075530 2002-05-28 Intravenous RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Milrinone Lactate Injection Is Indicated For The Short-Term Intravenous Treatment Of Patients With Acute Decompensated Heart Failure. Patients Receiving Milrinone Should Be Observed Closely With Appropriate Electrocardiographic Equipment. The Facility For Immediate Treatment Of Potential Cardiac Events, Which May Include Life-Threatening Ventricular Arrhythmias, Must Be Available. The Majority Of Experience With Intravenous Milrinone Has Been In Patients Receiving Digoxin And Diuretics. There Is No Experience In Controlled Trials With Infusions Of Milrinone For Periods Exceeding 48 Hours.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Milrinone Lactate MILRINONE LACTATE ZINC9224016

Comments